Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

Suven Life Sciences Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income ...

India-based Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 to ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi for a ₹3,395 crore IPO. The IPO is an offer for sale by promoters, ...

29 Jan, 2007 23 Mar, 2007 2 1 For every share held, the holder will receive 2 shares post the split adjustment. 04 Dec, 2003 15 Jan, 2004 10 2 For every share held, the holder will receive 5 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Wave Life Sciences shows promising data in genetic mutation treatments, with GSK collaborations and strong financial footing.

Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less traveled, thriving in dim and muddy river mouths, unlike most of its marine ... Six New Tree Species Named: 3 ...

Repligen Corporation (RGEN), a life sciences company, on Monday announced the launch of its CTech SoloVPE PLUS System, an advanced ...

South Korea has designated life sciences and biotechnology as priority ... biopharma investment and support for export of biomedical products Nurture human resources – Fostering talent in ...

The Balance Sheet Page of Suven Life Sciences Ltd. presents the key ratios, its comparison with the sector peers and 5 years of Balance Sheet.